Fundraising Fox

Rev1 Ventures

Venture studio

Columbus · Pre-Seed–Series A · 50 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Rev1 Ventures operates as a Midwest venture studio combining investors, operators, builders, and corporate innovators. It partners with early-stage founders in SaaS/AI, deep tech, and life sciences, helping them move faster by validating markets, gaining traction, and becoming venture ready. The firm aims to make the Midwest a magnet for diverse, high-growth startups by providing both strategic capital and operational support, positioning itself as a nexus of the regional startup community that improves founders' odds of reaching market successfully.

Invests inAI & Machine LearningBiotechDeep TechSaaSSector AgnosticColumbusNorth AmericaUnited States

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Series A
HQ
Columbus, Ohio, US
Leads rounds
Leads
Instruments
Equity
Founded
2005
AUM
$170M
Tracked investments
20

Team · 50 people

from the firm's website & public directories
Alison Lopriore· Managing Directorin
Andrea O'Carroll· Managing Director, Venture Platform
Andrea O’Carroll· Managing Director, Venture Platform
Carol Curtis, PhD· Advisory Partner
Dionnica Gaston· Managing Director of Talent
Michael Kindrat-Pratt· Managing Directorin
Amy Taylor· Board of Directors; President, Downtown Columbus, Inc.
Amy Whetsell· Executive Administrator
Andrea Ewing· Director, Corporate Partnerships
Chetan Kandhari· Board of Directors; Nationwide Insurance, Chief Innovation and Digital Officer
Constance Carpenter· Accounting Specialist
David Dennis· Board of Directors; Cardinal Health, VP of Strategy and Business Development
David Dillman· Chief Financial Officer & Chief Compliance Officer
David Meuse· Rev1 Chairman Emeritus; Stonehenge Partners
Dennis Durbin, MD, MSCE· Board of Directors; President, Abigail Wexner Research Institute at Nationwide Children’s Hospital
Destini B· Investorin
Dewey Rice· Creative Services Specialist
Erik Berg· Analystin
Jesse Longoria· Board of Directors; OhioHealth, SVP and Chief Strategy & Growth Officer
John M. Horack, PhD· Board of Directors; The Ohio State University, Vice President for Research
Juliet Klein· Senior Manager, Business Intelligence
Kim Zavislak· Board of Directors; KPMG, Columbus Office Managing Partner
Kirsten Haller· Sr. Market Intelligence Analyst
Kristy Campbell· Advisor
Larissa Cage· Manager, Entrepreneur Programs
London Thompson· Coordinator, Venture Studio Services
Marina Carey· Manager, Community Engagement
Megan Neff· Director, Partner Success
Mike Papadakis· Board of Directors; The Ohio State University, SVP and Chief Financial Officer
Samantha Drenski· Venture Platform Intern
Saruma Suzuki· Innovation Center Administrative Assistant
Shaun Young· Board of Directors; Nurx, SVP Operations
Sue Zazon· Board of Directors; Huntington Bank, President, Central Ohio Region
Terrence O’Donnell· Board of Directors; Dickinson Wright, Member and Government Relations Group Chair
Thien Bui· Manager, Venture Platform Services

What they invest in

from 13 of 20 portfolio companies

Healthtech ×7Medical Devices ×4AI & Machine Learning ×3SaaS ×3Biotech ×2Deep Tech ×2Digital Health ×2Creator Economy ×1

HQs:United States×15

Investments · 20 tracked

founders shown can be your intro path
smallTalksmalltalk.techin✓ verified

smallTalk develops technology products that support early childhood brain development through language exposure.

Deep TechEdTechHealthtechMedical DevicesColumbus, US

Dean Koch(Chief Executive Officer)Dr. Nathalie Maitre(Chief Science Officer)

Synotasynota.ioin𝕏✓ verified

Synota develops technology for decentralized energy systems.

AI & Machine LearningCrypto & Web3EnergyFintech<UNKNOWN>, US

Alan Schroeder(Director)Austin Mitchell(Chief Operating Officer & Director)Lisa Scott(Executive Officer, Director)

3Bar BiologicsSEC filingmedium confidence

Columbus, US

David Bergeron(Director)Bruce Caldwell(CEO)Richard Maksimoski(Director)Rashmi Agnihotri(Director)

Board seatDavid Bergeron· per SEC Form D · $2M raise · filed Apr 2017

Clarametyxclarametyx.comSEC filingmedium confidence

Clarametyx develops novel immune-enabling therapeutics targeting bacterial biofilms to modify disease progression in patients with chronic respiratory diseases.

BiotechHealthtechMedical DevicesColumbus, US

David Richards(Executive Officer)Peter G. Kleinhenz(Director)Michael Layman(Director)William Baumel(Director)Wayne Embree(Director)Chuck Bramlage(Director)

Board seatWayne Embree· per SEC Form D · $33.1M raise · filed Jan 2024

EduSourcedSEC filingmedium confidence

Columbus, US

Greg Pugh(Director)David Comisford(Executive Officer, Director)Rick Ainsworth(Director)Gregory Ruf(Director)

Board seatGreg Pugh· per SEC Form D · $1M raise · filed Mar 2015

Invirsa Inc.invirsa.com

Invirsa is a clinical-stage biopharmaceutical company developing DNA damage response therapeutics, with lead compound INV-102 in development for ocular conditions including sulfur mustard gas injury and diabetic dry eye disease.

BiotechDigital HealthMedical DevicesColumbus, US

Rachael Wingo(Executive Officer)Tim Willis(Director)Robert Shalwitz(Executive Officer, Director)Bethany George(Director)Michael Venerable(Director)

Board seatWayne Embree· per SEC Form D

Med-Compliance IQSEC filingmedium confidence

Powell, US

Brett P. Thornton(Executive Officer)David Bergeron(Director)Gary J. Ross(Executive Officer, Director)

Board seatDavid Bergeron· per SEC Form D · $430K raise · filed Sep 2016

Nexosome Oncology HoldingsSEC filingmedium confidence

HealthtechLexington, US

Alan Ezrin(Director)Todd Hembrough(Executive Officer, Director)Robert Saunders(Director)Brian Brohman(Director)Matthew Dicken(Director)

Board seatBrian Brohman· per SEC Form D · $4M raise · filed Nov 2021

smallTalk TechnologySEC filinghigh confidence

HealthtechChagrin Falls, US

Matthew McFarland(Director)Dean Koch(Director)Wayne Embree(Director)Margaret Groh(Director)

Board seatWayne Embree· per SEC Form D · $640K raise · filed Aug 2025

Super-H AnalyticsSEC filingmedium confidence

Columbus, US

Stephanie Hughes(Director)James Shields(Director)Jim Karam(Director)David Bergeron(Director)Nicole Weidner(Executive Officer, Director)

Board seatDavid Bergeron· per SEC Form D · $1.5M raise · filed Dec 2017

ZeoVationSEC filingmedium confidence

Columbus, US

David Bergeron(Director)Prabir Dutta(Director)Stephen R. Jones(Executive Officer, Director)Bo Wang(Executive Officer)

Board seatDavid Bergeron· per SEC Form D · $800K raise · filed May 2017

Healthy Rosterhealthyroster.comin

Healthy Roster provides documentation and management software for athletic trainers to streamline injury documentation, concussion testing, and continuing education compliance.

HealthtechSaaS

MentorcliQ

Columbus, US

Andy George(Executive Officer)Phillip George(Executive Officer)

Myoptechsmyoptechs.comin

Myoptechs develops treatments and interventions for myopia, a progressive eye disease that causes worsening distance vision and can lead to sight-threatening complications.

HealthtechMedical DevicesColumbus, US

Paul Grimm(Executive Officer, Director)inBrad Beasecker(Executive Officer)in

BoardWayne Embree(Director)Robin Sears(Director)in

Prevedereprevedere.comin

Board is an enterprise planning platform that unifies financial and operational planning with AI-driven agents to enable continuous planning and forecasting.

AI & Machine LearningData & InfrastructureEnterprise SoftwareColumbus, US

Richard C Wagner(Executive Officer, Director)

Rapchatrapchat.me𝕏

Rapchat is a mobile-first music creation platform that enables artists to record songs, discover beats, and collaborate with other creators.

Creator EconomyMedia & Entertainment

Sciotoagsciotoag.com
Senseicssenseics.com

SenseICs is a fabless semiconductor company that designs and develops integrated circuit (IC) chips and microelectronics hardware, including HDR Readout Integrated Circuits, tamper-resistant ICs, and wide-band GaN power amplifiers.

Deep TechHardwareSemiconductors

Take our surveytfaforms.com

TFA Forms provides secure data collection tools for online form creation and submission.

SaaS

Updox.comupdox.comin

Updox provides digital charge capture and revenue cycle management solutions for medical practices, enabling automated billing and payment processing.

AI & Machine LearningDigital HealthHealthtechSaaSDublin, US

PAT BICKLEY(Executive Officer)RITCH NEWPORT(Executive Officer)HEATHER MILLS(Executive Officer)MARK D. SHARY(Director)RYAN ENGLE(Director)SEAN RAMSEY(Executive Officer)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Frequently asked questions

What stage does Rev1 Ventures invest at?
Rev1 Ventures invests at the Pre-Seed, Seed, Series A stages.
What sectors does Rev1 Ventures focus on?
Rev1 Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, SaaS, Sector Agnostic.
Where is Rev1 Ventures located?
Rev1 Ventures is headquartered in Columbus, US.
Does Rev1 Ventures lead rounds?
Yes, Rev1 Ventures leads investment rounds.

From the blog

visit blog ↗

Rev1 Ventures recently highlighted how corporate partnerships strengthen regional startup ecosystems, reported $718.1M in economic impact from portfolio companies in 2025, and opened a downtown Columbus innovation hub that achieved rapid adoption with over 50 members. AI summary

Media · Podcasts & interviews

featuring the team

Closing the Gap with Alicia Oddi, Rev1 Ventures

614startups · Alicia Oddi

Images

Rev1 Ventures photo

Co-investors · 1

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.

$250K

Firms observed investing alongside Rev1 Ventures, from public investor directories. Shared companies are the overlap with Rev1 Ventures's recorded portfolio.

Similar investors

Featured in lists